STOCK TITAN

Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

Key Terms

lab execution system technical
A lab execution system is software that guides, schedules and records laboratory work, making sure procedures are followed, data are captured consistently, and regulatory steps are documented. For investors, it matters because it acts like a digital factory foreman for scientific work—reducing mistakes, speeding development, improving reproducibility and audit readiness—which can lower costs, shorten time to market and protect value in regulated industries.
usp methodconnect regulatory
USP MethodConnect is a digital service from the organization that sets medicine and laboratory standards, providing up-to-date official test methods and procedures used to check the identity, purity and strength of drugs and ingredients. For investors, it matters because access to these standardized methods helps manufacturers meet regulatory requirements and avoid costly recalls or delays—think of it as the rulebook and toolkit labs use to prove a product is safe and compliant.
usp–nf regulatory
USP–NF is a combined set of official quality standards and testing methods for medicines and health-care ingredients used in the United States, like a trusted recipe book and checklist for drug quality. Investors care because meeting these standards affects whether products can be sold, helps avoid recalls or regulatory trouble, and influences manufacturing costs and supplier choices—factors that can change a company’s revenue and risk profile.
monographs medical
Monographs are detailed, authoritative documents that describe a drug, medical product, ingredient or scientific topic, summarizing its composition, approved uses, safety data, testing methods and evidence of effectiveness. They are issued by regulators, scientific bodies or expert panels and act like a technical product manual or report card. Investors watch monographs because they shape regulatory approval, labeling, market access and perceived safety — factors that affect sales, legal risk and company value.
sops technical
Standard operating procedures are written, step-by-step instructions that tell employees how to perform key tasks consistently and safely—like a recipe or instruction manual for a business process. For investors, strong SOPs mean fewer mistakes, smoother production or trial conduct, better regulatory compliance, and more reliable timelines, which reduce operational risk and make future performance easier to predict.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the introduction of OpenLab Sync, a new Lab Execution System (LES) that enables laboratories to digitally connect scientific workflows from method design through execution at the bench. OpenLab Sync extends Agilent’s OpenLab laboratory informatics portfolio beyond traditional data and sample management, enabling guided, standardized, and traceable execution of laboratory work in regulated environments.

As laboratories face increasing regulatory scrutiny, workforce turnover, and pressure to standardize operations across sites, many continue to rely on static, paper-based procedures that can introduce variability and risk. OpenLab Sync addresses growing demands for consistency, data integrity, and audit readiness in regulated environments by providing step-by-step, guided digital workflows that help reduce ambiguity in laboratory procedures while improving traceability of bench-level activities across teams and locations.

OpenLab Sync connects to USP MethodConnect through a plug-in developed by Agilent, making Agilent the first integrator of the platform. This integration enables USP’s machine-readable USP–NF test method content, including Monographs, General Chapters, and SOPs, to be ingested directly into guided protocols, transforming static SOPs into fully digital, operational procedures that help reduce ambiguity, supporting faster onboarding, greater confidence in execution, and improved scalability.

“Execution at the bench has remained one of the last gaps in laboratory digitalization. With OpenLab Sync, we are helping laboratories close that gap by supporting more consistent, confident, and compliant execution through a bench-friendly digital experience aligned with modern quality and data integrity expectations. Our collaboration with the United States Pharmacopeia helps laboratories become productive faster while maintaining confidence in both their methods and software,” said Shweta Shukradas, associate vice president of Automated Lab Productivity Solutions at Agilent.

"USP MethodConnect is designed to work across the laboratory informatics ecosystem, and this first integration with OpenLab Sync shows what that work looks like in practice. We look forward to working with integrators across the industry to make verified USP–NF workflows available to every lab that relies on them," said Vimala Raghavendran, vice president of Informatics Product Development at USP.

To further support lab managers, OpenLab Sync applies AI to streamline system setup and day-to-day use by helping reduce the time required to configure instrument integrations and guided workflows during installation. AI-enabled capabilities also provide advanced features such as powering instrument integration, workflow configuration, system monitoring, semantic search, and summarization.

Designed for pharmaceutical quality control and other regulated environments, OpenLab Sync helps organizations improve operational consistency, support compliance initiatives, and scale standardized workflows globally within Agilent’s unified OpenLab digital ecosystem.

OpenLab Sync is available globally as part of the Agilent OpenLab portfolio.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Media Contact
Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com

Source: Agilent Technologies Inc.